Combining an Hsp70 inhibitor with either an N- or C-terminal Hsp90 inhibitor produces mechanistically distinct phenotypes

被引：13

作者：

Wang, Y. ^{[1
]}

McAlpine, S. R. ^{[1
]}

机构：

[1] Univ New S Wales, Dept Chem, Sydney, NSW 2052, Australia

来源：

ORGANIC & BIOMOLECULAR CHEMISTRY | 2015年 / 13卷 / 12期

关键词：

SHOCK-PROTEIN; 90; INDUCED APOPTOSIS; SMALL-MOLECULE; CANCER; SANSALVAMIDE; BINDING;

D O I：

10.1039/c5ob00147a

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Blocking the function of both heat shock protein 90 and 70 (Hsp90 and Hsp70) simultaneously limits these chaperones' cytoprotective effects on cancer cells. The unique phenotype associated with modulating Hsp90's C-terminus, when used in combination with Hsp70 inhibitors, produces a synergistic and highly relevant dual chemotherapy regimen.

引用

页码：3691 / 3698

页数：8

共 23 条

[11] Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90
Kunicki, Joseph B.
Petersen, Mark N.
Alexander, Leslie D.
Ardi, Veronica C.
McConnell, Jeanette R.
McAlpine, Shelli R.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) : 4716 - 4719
[12] LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861
[13] Targeting HSP90 for cancer therapy
Mahalingam, D.
Swords, R.
Carew, J. S.
Nawrocki, S. T.
Bhalla, K.
Giles, F. J.
[J]. BRITISH JOURNAL OF CANCER, 2009, 100 (10) : 1523 - 1529
[14] A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells
Massey, Andrew J.
Williamson, Douglas S.
Browne, Helen
Murray, James B.
Dokurno, Pawel
Shaw, Terry
Macias, Alba T.
Daniels, Zoe
Geoffroy, Stephanie
Dopson, Melanie
Lavan, Paul
Matassova, Natalia
Francis, Geraint L.
Graham, Christopher J.
Parsons, Rachel
Wang, Yikang
Padfield, Antony
Comer, Mike
Drysdale, Martin J.
Wood, Mike
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 535 - 545
[15] A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response
McConnell, Jeanette R.
Alexander, Leslie A.
McAlpine, Shelli R.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (02) : 661 - 666
[16] Heat shock protein 90: the cancer chaperone
Neckers, Len
[J]. JOURNAL OF BIOSCIENCES, 2007, 32 (03) : 517 - 530
[17] Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors
Reikvam, Hakon
Nepstad, Ina
Sulen, Andre
Gjertsen, Bjorn Tore
Hatfield, Kimberley Joanne
Bruserud, Oystein
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (05) : 551 - 563
[18] Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivatives
Sellers, Robert P.
Alexander, Leslie D.
Johnson, Victoria A.
Lin, Chun-Chieh
Savage, Jeremiah
Corral, Ricardo
Moss, Jason
Slugocki, Tim S.
Singh, Erinprit K.
Davis, Melinda R.
Ravula, Suchitra
Spicer, Jamie E.
Oelrich, Jenna L.
Thornquist, Andrea
Pan, Chung-Mao
McAlpine, Shelli R.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (18) : 6822 - 6856
[19] Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
Taipale, Mikko
Krykbaeva, Irina
Koeva, Martina
Kayatekin, Can
Westover, Kenneth D.
Karras, Georgios I.
Lindquist, Susan
[J]. CELL, 2012, 150 (05) : 987 - 1001
[20] Mechanistic Studies of Sansalvamide A-Amide: An Allosteric Modulator of Hsp90
Vasko, Robert C.
Rodriguez, Rodrigo A.
Cunningham, Christian N.
Ardi, Veronica C.
Agard, David A.
McAlpine, Shelli R.
[J]. ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (01): : 4 - 8

← 1 2 3 →